Association between transfusion with human herpesvirus 8 antibody-positive blood and subsequent mortality

Journal of Infectious Diseases

Volumn 206, Issue 10, 2012, Pages 1497-1503

  Hladik, Wolfgang ^a,c   Pellett, Philip E ^d   Hancock, John ^a   Downing, Robert ^a   Gao, Hongjiang ^a   Packel, Laura ^f   Mimbe, Derrick ^a   Nzaro, Esau ^b   Mermin, Jonathan ^e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MULAGO HOSPITAL   (Uganda)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d WAYNE STATE UNIVERSITY   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN HERPESVIRUS 8 ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD DONOR; CHILD; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HERPES VIRUS INFECTION; HOSPITALIZATION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; MORTALITY; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; SCHOOL CHILD; TRANSFUSION; UGANDA;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HIV INFECTIONS; HUMANS; INFANT; MALE; MIDDLE AGED; RISK FACTORS; UGANDA; YOUNG ADULT;

EID: 84867706311     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis543     Document Type: Article

References (18)

1. Henke-Gendo C, Schulz TF. Transmission and disease association of Kaposi's sarcoma-associated herpesvirus: recent developments. Curr Opin Infect Dis 2004; 17:53-7.
2. Dedicoat M, Newton R. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer 2003; 88:1-3.
3. Blackbourn DJ, Ambroziak J, Lennette E, Adams M, Ramachandran BLevy JA. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 1997; 349:609-11.
4. Dollard SC, Nelson KE, Ness PM, et al. Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort. Transfusion 2005; 45:500-3.
5. Enbom M, Urassa W, Massambu C, Thorstensson R, Mhalu F, Linde A. Detection of human herpesvirus 8 DNA in serum from blood donors with HHV-8 antibodies indicates possible bloodborne virus transmission. J Med Virol 2002; 68:264-7.
6. Hladik W, Dollard SC, Mermin J, et al. Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med 2006; 355:1331-8.
7. Chen L, Lin DY, Zeng D. Attributable fraction functions for censored event times. Biometrika 2010; 97:713-26.
8. Roberts TC, Buller RS, Gaudreault-Keener M, et al. Effects of storage temperature and time on qualitative and quantitative detection of cytomegalovirus in blood specimens by shell vial culture and PCR. J Clin Microbiol 1997; 35:2224-8.
9. Roback JD. CMV and blood transfusions. Rev Med Virol 2002; 12:211-9.
10. Andreoni M, Sarmati L, Nicastri E, et al. Primary human herpesvirus 8 infection in immunocompetent children. JAMA 2002; 287:1295-300.
11. Wang QJ, Jenkins FJ, Jacobson LP, et al. Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood 2001; 97:2366-73.
12. Oksenhendler E, Cazals-Hatem D, Schulz TF, et al. Transient angiolymphoid hyperplasia and Kaposi's sarcoma after primary infection with human herpesvirus 8 in a patient with human immunodeficiency virus infection. N Engl J Med 1998; 338:1585-90.
13. Thaunat O, Mamzer-Bruneel MF, Agbalika F, et al. Severe human herpesvirus-8 primary infection in a renal transplant patient successfully treated with anti-CD20 monoclonal antibody. Blood 2006; 107:3009-10.
14. Luppi M, Barozzi P, Schulz TF, et al. Bone marrow failure associated with human herpesvirus 8 infection after transplantation. N Engl J Med 2000; 343:1378-85.
15. Pietrosi G, Vizzini G, Pipitone L, et al. Primary and reactivated HHV8 infection and disease after liver transplantation: a prospective study. Am J Transplant 2011; 11:2715-23.
16. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood 2001; 97:1180-95.
17. Blajchman MA. Immunomodulation and blood transfusion. Am J Ther 2002; 9:389-95.
18. Kao KJ. Mechanisms and new approaches for the allogeneic blood transfusion-induced immunomodulatory effects. Transfus Med Rev 2000; 14:12-22.